Logo

Personalis

In Brief This Week: Personalis, Burning Rock, Thermo Fisher, Caris Life Sciences, More

News items for the week of Jan. 3, 2023.

Losses Deep and Widespread as GenomeWeb Top 40 Drops 34 Percent in 2022

All but two Top 40 companies declined, with over half losing more than 50 percent of their value and 13 companies losing three-quarters of their value or more.

People in the News at Personalis, Roche, Massive Bio, SeqLL, More

Executive appointments, promotions, and departures in omics and molecular diagnostics for the week of Dec. 12, 2022.

Personalis, UCSF to Study ctDNA Utility in Colorectal Cancer Treatment Response Monitoring

Researchers will employ the company's tumor-informed, personalized assays to analyze ctDNA patterns linked to immunotherapy drug response.

People in the News at Pacific Biosciences, Personalis, Epic Sciences, Cytek Biosciences, More

Executive appointments, promotions, and departures in omics and molecular diagnostics for the week of Oct. 31, 2022.

Nov 3, 2022

Personalis Q3 Revenues Down 33 Percent on Disputed VA Contract

Oct 4, 2022

Personalis, Duke University, Olink Collaborate on Immunotherapy Markers in Gastric Cancer

Sep 7, 2022

Larger Liquid Biopsy Panels Loom, But Patient Benefit Still Uncertain
Premium

Aug 18, 2022

Personalis Adds Newly Issued Patent to Foresight Diagnostics Infringement Suit

Aug 15, 2022

Personalis, BC Cancer Partner on Study of ctDNA MRD Tests for Colorectal, Pancreatic Cancers

Aug 5, 2022

Earnings Roundup: Waters, Personalis, Opko Health, Biodesix, Exagen

Aug 2, 2022

Personalis Sues Foresight Diagnostics, Alleging Patent Infringement

May 6, 2022

Personalis Building Data for High-Sensitivity Residual Cancer Assay
Premium

May 4, 2022

Personalis Q1 Revenues Drop 27 Percent

Apr 26, 2022

Evaxion Biotech Adopts Personalis Immune Profiling Platform for Melanoma Immunotherapy Trial

Feb 28, 2022

Personalis Locks in Clinical Launch Plans as Oncology Testing Takes Lead Over Population Sequencing
Premium

Feb 24, 2022

Personalis Q4 Revenues Bump up 3 Percent

Feb 15, 2022

Personalis, UCSD Cancer Center Ink Clinical Genomic Testing, Research Partnership

Jan 7, 2022

Personalis Reports Preliminary Q4 Revenues up More Than 2 Percent

Jan 4, 2022

Fulgent Genetics, Bio-Techne Lead Winners as GenomeWeb Index Gains 12 Percent in 2021

Jan 3, 2022

Personalis Signs Deal With BTIG for $100M At-Market Stock Offering

Dec 17, 2021

New Products Posted to GenomeWeb: Thermo Fisher, Personalis, Menarini Silicon Biosystems, More

Nov 4, 2021

Personalis Q3 Revenues Climb 12 Percent

Oct 15, 2021

People in the News: New Appointments at Grail, Foundation Medicine, Personalis, More

Oct 13, 2021

Mayo Clinic, Personalis Ink Comprehensive Genomics Research Collaboration

Breaking News
The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.